Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Feb 6, 2018 · 10-K · 37 days after period end · 0001069530-18-000004
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$2.42M | -$2.52M | -$4.52M | -$2.16M |
| EPS Diluted | — | -$0.06 | -$0.10 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Feb 6, 2018 · 37 d after period end
